New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
10:03 EDTGNC, BAX, FB, ARCP, AAN, FSYS, GCO, SBGI, KMR, GTN, CAM, FMC, NXST, HII, GD, ATW, VRSN, NOV, HRS, STZOn The Fly: Analyst Downgrade Summary
Atwood Oceanics (ATW) downgraded to Buy from Conviction Buy at Goldman... Cameron (CAM) downgraded to Neutral from Buy at Goldman... Constellation Brands (STZ) downgraded to Neutral from Buy at Goldman... General Dynamics (GD) downgraded to Equal Weight from Overweight at Barclays... Gray Television (GTN) downgraded to Market Perform from Outperform at Wells Fargo... Harris (HRS) downgraded to Underweight from Equal Weight at Barclays... Huntington Ingalls (HII) downgraded to Underweight from Equal Weight at Barclays... Kinder Morgan Management (KMR) downgraded to Market Perform at Wells Fargo... National Oilwell (NOV) downgraded to Neutral from Buy at Goldman... Nexstar (NXST) downgraded to Market Perform from Outperform at Wells Fargo... Sinclair Broadcast (SBGI) downgraded to Market Perform from Outperform at Wells Fargo... VeriSign (VRSN) downgraded to Market Perform from Outperform at Cowen... FMC Corporation (FMC) downgraded to Neutral from Outperform at Macquarie... Genesco (GCO) downgraded to Equal Weight from Overweight at Johnson Rice... Fuel Systems (FSYS) downgraded to Hold from Buy at Lake Street... American Realty (ARCP) downgraded to Neutral from Buy at Ladenburg... Baxter (BAX) at Goldman downgraded to Buy from Conviction Buy at Goldman... Aaron's (AAN) downgraded to Market Perform from Outperform at Raymond James... Facebook (FB) downgraded to Hold from Buy at Argus... GNC Holdings (GNC) downgraded to Neutral from Outperform at Credit Suisse.
News For ATW;CAM;STZ;GD;GTN;HRS;HII;KMR;NOV;NXST;SBGI;VRSN;FMC;GCO;FSYS;ARCP;BAX;AAN;FB;GNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
June 22, 2015
16:00 EDTFBOptions Update; June 22, 2015
iPath S&P 500 VIX Short-Term Futures down 78c to 17.45. Option volume leaders: AAPL FB BAC CHK WMB BABA TWTR MU AMBA TSLA JPM
14:42 EDTFBOculus potential not reflected in Facebook's stock price, Piper Jaffray says
Subscribe for More Information
09:40 EDTFBActive equity options trading on open
Subscribe for More Information
07:31 EDTFBFacebook catching up to YouTube in video ads, Reuters says
Facebook (FB) is gaining market share on Google's (GOOG) YouTube in online video advertising, reports Reuters, citing a published Ampere Analysis report. Reference Link
06:32 EDTBAXKamada collaborates with Baxter on clinical trial with Alpha-1 antitrypsin
Kamada (KMDA) reports that the company has entered into a collaboration with Baxalta International, a wholly-owned subsidiary of Baxter (BAX) on a Phase 1/2 clinical trial of Kamada’s proprietary alpha-1 antitrypsin treatment for the prevention of lung transplant rejection. Under the agreement, Baxalta will collaborate in the development and funding of the study, which will be conducted in Israel. The study is expected to initiate in the first half of 2016, with more details on trial design to be provided at a later date. Kamada’s proprietary, highly-purified, liquid form of human AAT has shown positive interim results in a proof-of-concept Phase II study in Graft-versus-Host-Disease conducted at the Fred Hutchinson Cancer Research Center in cooperation with Baxalta. Based on those results, preclinical data published in Blood, and at the American Society of Hematology meeting, and a similar mechanism of action, the companies now plan to expand the AAT indication to the prevention of lung transplant rejection and may use this data to support clinical development worldwide. Baxalta has distribution rights to intravenous AAT for all indications in the U.S., Canada, Australia and New Zealand, while Kamada has rights in all other territories and all other formulations.
06:25 EDTFBFacebook's CPO to outline new format for mobile advertising, WSJ reports
Subscribe for More Information
06:03 EDTFBFacebook price target raised to $120 from $92 at Piper Jaffray
Piper Jaffray analyst Gene Munster raised his price target for shares of Facebook to $120 and keeps an Overweight rating on the name. Facebook is the best play on the "next computer paradigm of virtual reality," Munster tells investors this morning in a research note. Oculus, the company's virtual reality technology, is an "insurance policy on the relevance of Facebook's social portfolio as technology shifts,” Munster writes. He believes the long-term value of technology is not reflected in the current share price. The social networking giant closed Friday down 39c to $82.51.
June 19, 2015
18:12 EDTBAXS&P announces changes to S&P 100, 400, 500, and 600 indices
S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: S&P 500 constituent The Priceline Group (PCLN) will replace Baxter International (BAX) in the S&P 100, Baxalta (BXLT) will replace QEP Resources (QEP) in the S&P 500, QEP Resources will replace Itron (ITRI) in the S&P MidCap 400, and Itron will replace Arch Coal (ACI) in the S&P SmallCap 600 after the close of trading on Tuesday, June 30. Baxter International is spinning off Baxalta in a transaction expected to be completed on that date. Baxter International will remain in the S&P 500 following the distribution, but its post spin market capitalization will no longer make it appropriate for the S&P 100. QEP Resources, Itron and Arch Coal are all ranked near or at the bottom of their current indices. Skechers USA (SKX) will replace Rock-Tenn Co. (RKT) in the S&P MidCap 400, and MiMedx Group (MDXG) will replace Skechers USA in the S&P SmallCap 600 after the close of trading on Tuesday, June 30. S&P 500 constituent MeadWestvaco Corp. (MWV) is combining with Rock-Tenn in a transaction expected to be completed on or about that date. The combined company will remain in the S&P 500 and will change its name to WestRock Co. HealthEquity (HQY) will replace Zep Inc. (ZEP) in the S&P SmallCap 600 after the close of trading on Thursday, June 25. Private equity firm New Mountain Capital is acquiring Zep in a transaction expected to be completed on or about that date pending final approvals.
17:19 EDTBAXPriceline to replace Baxter in S&P 100 as of 6/30 close
Subscribe for More Information
16:00 EDTFBOptions Update; June 19, 2015
iPath S&P 500 VIX Short-Term Futures up 11c to 18.21, Option volume leaders: AAPL TWTR BAC T FB GILD NFLX BABA AAL MU AMZN
09:37 EDTFBActive equity options trading on open
Subscribe for More Information
07:51 EDTFBGameStop CFO says 'blown away' by Microsoft virtual reality demonstration
Subscribe for More Information
06:11 EDTFBFacebook implied volatility of 21 at lower end of index mean range
Subscribe for More Information
June 18, 2015
19:48 EDTFBFacebook Moments not available in Europe due to regulator concerns, WSJ says
Facebook's photo app, Moments, will not be available in Europe due to regulators' concerns over facial recognition technology, reports the Wall Street Journal, citing Facebook’s head of policy in Europe, Richard Allan. Reference Link
14:21 EDTARCPAmerican Realty appoints Mark Ordan as additional independent director
Last night, American Realty Capital Properties announced the appointment of Mark Ordan as an Independent Director and a member of the Audit Committee and the Nominating and Corporate Governance Committee of the Company's Board of Directors effective today.
12:04 EDTFBActive options: AAPL ORCL FB RAD BAC HTZ MU GE TSLA AMZN BABA KO
Subscribe for More Information
09:35 EDTFBActive equity options trading on open
Subscribe for More Information
07:38 EDTFBFacebook continues to take ad share, says JMP Securities
JMP Securities says its checks indicate that Facebook's share of total ad dollars continue to rise. The firm believes that Instagram's engagement and monthly average users continue to grow. It estimates that Instagram could generate about $1,4B in revenue next year, versus its 2015 estimate of about $445M. JMP Securities raised its price target on Facebook to $101 from $98 and keeps an Outperform rating on the shares.
07:30 EDTFBSalesforce initiatives should help social media companies, says Brean Capital
Subscribe for More Information
06:13 EDTFBFacebook testing new approach to hiring to diversify employee ranks, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use